表紙:遺伝子検査の世界市場(2021年~2025年)
市場調査レポート
商品コード
1006642

遺伝子検査の世界市場(2021年~2025年)

Global Genetic Testing Market 2021-2025

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円
遺伝子検査の世界市場(2021年~2025年)
出版日: 2021年04月08日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

遺伝子検査の市場規模は、2021年から2025年の間に約12%のCAGRで推移し、53億9,000万米ドルの成長が見込まれています。

遺伝子検査市場に関する当レポートは、全体的な分析、市場規模と予測、動向、成長要因、および課題、ならびに約25のベンダーをカバーするベンダー分析を提供します。

同市場は、遺伝子疾患および遺伝的障害の有病率の上昇、高度な遺伝子検査製品の承認の増加、および遺伝子検査のコスト削減による手頃な価格の向上によって促進されています。さらに、遺伝性疾患および遺伝的障害の有病率の上昇は、市場の成長も後押しすると予想されます。

当レポートでは、遺伝子検査市場を調査しており、市場の概要、市場規模、市場の見通し、顧客情勢、製品別・アプリケーション別・地域別の分析、さらにベンダー情勢とベンダー分析などを提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2020年
  • 市場の見通し:2020年から2025年の予測

ファイブフォース分析

製品別の市場セグメンテーション

  • マーケット・セグメント
  • 製品別の比較
  • 機器:市場規模と予測(2020年~2025年)
  • 消耗品:市場規模と予測(2020年~2025年)
  • 製品別の市場機会

アプリケーション別セグメンテーション

  • 予測および診断テスト
  • 薬理ゲノミクス試験

顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測(2020年~2025年)
  • 欧州:市場規模と予測(2020年~2025年)
  • アジア:市場規模と予測(2020年~2025年)
  • その他:市場規模と予測(2020年~2025年)
  • 主要国
  • 地域の市場機会
  • 市場成長促進要因
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • ベンダー情勢
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

付録

目次
Product Code: IRTNTR40152

Technavio has been monitoring the genetic testing market and it is poised to grow by $ 5.39 billion during 2021-2025, progressing at a CAGR of about 12% during the forecast period. Our report on the genetic testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of genetic diseases and disorders, rising approval of advanced genetic testing products, and increasing affordability due to reduction in the cost of genetic testing. In addition, the rising prevalence of genetic diseases and disorders is anticipated to boost the growth of the market as well.

The genetic testing market analysis includes product segment and geographic landscape.

Technavio's genetic testing market is segmented as below:

By Product

  • Equipment
  • Consumables

By Geography

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the advancements in next-generation sequencing as one of the prime reasons driving the genetic testing market growth during the next few years. Also, the growing adoption of direct-to-consumer genetic tests in early disease diagnosis and the growing adoption of pharmacogenetic testing in reducing adverse drug events will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on genetic testing market covers the following areas:

  • Genetic testing market sizing
  • Genetic testing market forecast
  • Genetic testing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genetic testing market vendors that include Abbott Laboratories, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Quest Diagnostics Inc., and Thermo Fisher Scientific Inc. Also, the genetic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Equipment - Market size and forecast 2020-2025
  • Consumables - Market size and forecast 2020-2025
  • Market opportunity by Product

Segmentation by Application

  • Predictive and diagnostic testing
  • Pharmacogenomic testing

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Equipment - Market size and forecast 2020-2025 ($ million)
  • 24: Equipment - Year-over-year growth 2020-2025 (%)
  • 25: Consumables - Market size and forecast 2020-2025 ($ million)
  • 26: Consumables - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Abbott Laboratories - Overview
  • 48: Abbott Laboratories - Business segments
  • 49: Abbott Laboratories - Key offerings
  • 50: Abbott Laboratories - Key customers
  • 51: Abbott Laboratories - Segment focus
  • 52: Agilent Technologies Inc. - Overview
  • 53: Agilent Technologies Inc. - Business segments
  • 54: Agilent Technologies Inc. - Key offerings
  • 55: Agilent Technologies Inc. - Key customers
  • 56: Agilent Technologies Inc. - Segment focus
  • 57: bioMerieux SA - Overview
  • 58: bioMerieux SA - Business segments
  • 59: bioMerieux SA - Key offerings
  • 60: bioMerieux SA - Key customers
  • 61: bioMerieux SA - Segment focus
  • 62: Bio-Rad Laboratories Inc. - Overview
  • 63: Bio-Rad Laboratories Inc. - Business segments
  • 64: Bio-Rad Laboratories Inc. - Key offerings
  • 65: Bio-Rad Laboratories Inc. - Key customers
  • 66: Bio-Rad Laboratories Inc. - Segment focus
  • 67: F. Hoffmann-La Roche Ltd. - Overview
  • 68: F. Hoffmann-La Roche Ltd. - Business segments
  • 69: F. Hoffmann-La Roche Ltd. - Key offerings
  • 70: F. Hoffmann-La Roche Ltd. - Key customers
  • 71: F. Hoffmann-La Roche Ltd. - Segment focus
  • 72: Illumina Inc. - Overview
  • 73: Illumina Inc. - Product and service
  • 74: Illumina Inc. - Key offerings
  • 75: Illumina Inc. - Key customers
  • 76: Illumina Inc. - Segment focus
  • 77: Myriad Genetics Inc. - Overview
  • 78: Myriad Genetics Inc. - Business segments
  • 79: Myriad Genetics Inc. - Key offerings
  • 80: Myriad Genetics Inc. - Key customers
  • 81: Myriad Genetics Inc. - Segment focus
  • 82: QIAGEN NV - Overview
  • 83: QIAGEN NV - Business segments
  • 84: QIAGEN NV - Key offerings
  • 85: QIAGEN NV - Key customers
  • 86: QIAGEN NV - Segment focus
  • 87: Quest Diagnostics Inc. - Overview
  • 88: Quest Diagnostics Inc. - Business segments
  • 89: Quest Diagnostics Inc. - Key offerings
  • 90: Quest Diagnostics Inc. - Key customers
  • 91: Quest Diagnostics Inc. - Segment focus
  • 92: Thermo Fisher Scientific Inc. - Overview
  • 93: Thermo Fisher Scientific Inc. - Business segments
  • 94: Thermo Fisher Scientific Inc. - Key offerings
  • 95: Thermo Fisher Scientific Inc. - Key customers
  • 96: Thermo Fisher Scientific Inc. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations